ERBB2 and breast carcinoma: Although it is primarily classified on the basis of ER, progesterone receptor (PR), and human epidermal growth factor 2 (ErbB2/neu or HER2) receptor expression, breast cancer is a heterogeneous disease with multiple molecular subtypes that differ in terms of both clinical behavior and response to therapy [35,36,37].